The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design.

Rachel Peterson, MD, Head of Clinical Immunology, will provide a safety update from the PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active LN, which was discontinued and ...